Listed since 1987
The VBG Group’s Series B share is traded on Nasdaq Stockholm Mid Cap under the ticker VBG B. The Series A shares, which represent 52 per cent of the votes in the VBG Group, are held by three foundations: the Herman Krefting Foundation for Allergy and Asthma Research, the SLK Employees’ Foundation and the VBG-SLK Foundation.
Dividend and dividend policy
Since the company’s initial listing on the stock exchange in 1987, and including the dividend of SEK 4.50 (3.25) proposed by the Board to the 2019 Annual General Meeting, the company has paid an average dividend amounting to 34.8% of the net profit. The average over the past ten years amounted to 39.2%.
In March 2012, the Board of Directors adopted a policy stipulating 30 per cent as the level of the dividend the shareholders can expect under normal circumstances. The proposed dividend for fiscal year 2018 is equivalent to 41.2% (36.9) of the Group’s net profit.
Per share data
|Dividend, SEK||4.50*||3.25||3.50 (1.75**)||3.25||3.00|
|Share price, SEK||126.80||132.00||160.50||121.00||103.75|
|Share price adjusted, SEK (as regards new share issue)||126.80||132.00||111.19||83.83||71.88|
|Cash flow from operating activities, SEK||10.14||10.63||20.08||11.61||9.81|
|Dividend yield, %||3.55||2.46||2.18||2.69||2.89|
|Total number of outstanding shares (thousands)||25,004||25,004||12,502||12,502||12,502|
|Average number of outstanding shares (thousands)||25,004||22,920||12,502||12,502||12,502|
*Proposed dividend per share.
**Dividend per share based on doubling of the number of outstanding shares o 25,004,048 after the new share issue in February 2017.